Transcranial brain parenchyma sonography in movement disorders: State of the artUwe Walter, Daniela Berg, Stefanie Behnke et al.|Ultrasound in Medicine & Biology|2006Cited by 237
Trial of Deferiprone in Parkinson’s DiseaseDavid Devos, Christoph Scherfler, Bart Post et al.|New England Journal of Medicine|2022Cited by 226
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's diseaseDaniela Berg, Werner Poewe, Stefanie Behnke et al.|Movement Disorders|2012Cited by 129
The <scp>PRIPS</scp> study: screening battery for subjects at risk for <scp>P</scp>arkinson's diseaseDaniela Berg, Jana Godau, Klaus Seppi et al.|European Journal of Neurology|2012Cited by 125
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson diseaseHelmine Hochstrasser, Daniela Berg, Peter Bauer et al.|Neurology|2004Cited by 112